ADMA Biologics ADMA Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $165.35M-20.0% | $146.93M-25.7% | $209.45M+207% | $208.93M+501% | $206.77M+5,773% | ||
| $7.8M+1.3% | $7.9M+2.6% | $7.9M+11.6% | $7.8M+7.3% | $7.7M+3.1% | ||
| $21.73M+35.0% | $20.03M+47.1% | $20.07M+102% | $18.2M+116% | $16.1M+123% | ||
| $128.32M+26.8% | $50.4M-57.5% | $64.97M-24.5% | $76.71M+5.1% | $101.22M+375% | ||
| $20.42M+93.0% | $22.58M+174% | $24.25M+264% | $10.94M+71.8% | $10.58M+105% | ||
| -$14.77M-35.1% | -$21.89M-155% | -$24.37M-237% | -$11.1M-61.0% | -$10.93M-103% | ||
| —— | —— | —— | —— | —— | ||
| -$47.07M+26.4% | -$44.07M+24.4% | -$65.98M+0.4% | -$63.62M-57.5% | -$63.98M-59.9% | ||
| —— | —— | —— | —— | $27.84M+163% | ||
| $107.9M+19.1% | $27.82M-74.8% | $40.73M-48.7% | $65.77M-1.3% | $90.64M+462% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does ADMA Biologics generate?
- ADMA Biologics (ADMA) generated $128.3M in operating cash flow over the trailing twelve months.
- What is ADMA Biologics's free cash flow?
- After $20.4M of capital expenditures, ADMA Biologics's free cash flow was $107.9M over the trailing twelve months, up 19.1% year over year.
- Where does ADMA Biologics's cash flow data come from?
- Every line is extracted from ADMA Biologics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
